US Bancorp’s Core Scientific CORZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$400K Buy
15,622
+2,391
+18% +$56.3K ﹤0.01% 1720
2026
Q1
$198K Buy
13,231
+4,248
+47% +$72.5K ﹤0.01% 2027
2025
Q4
$131K Sell
8,983
-6,536
-42% -$114K ﹤0.01% 2240
2025
Q3
$278K Buy
15,519
+4,863
+46% +$71.3K ﹤0.01% 1831
2025
Q2
$182K Buy
10,656
+1,974
+23% +$19.8K ﹤0.01% 2070
2025
Q1
$62.9K Buy
8,682
+1,663
+24% +$18.9K ﹤0.01% 2628
2024
Q4
$98.6K Buy
+7,019
New +$104K ﹤0.01% 2405

Other funds holding CORZ

US Bancorp's CORZ Position: Q2 2026 in Review

US Bancorp increased its Core Scientific (CORZ) stake by 18% in Q2 2026, buying an estimated $56.3K and bringing the position to 15,622 shares worth $400K. The position accounts for ﹤0.01% of the portfolio, ranked #1720.

US Bancorp first reported a position in CORZ in Q4 2024 and has held it in 7 quarters since. 412 funds tracked by Wall St. Rank hold CORZ as of Q2 2026.

  • US Bancorp held 15,622 shares of Core Scientific worth $400K as of Q2 2026.
  • US Bancorp bought 2,391 Core Scientific shares in Q2 2026, an estimated $56.3K.
  • Core Scientific made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #1720 holding.
  • US Bancorp first reported a position in Core Scientific in Q4 2024 and has held it in 7 quarters since.
  • 412 funds tracked by Wall St. Rank held Core Scientific as of Q2 2026.

Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.